Gene · 7409
Papers3,486
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,486
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy. | Cell Host Microbe | 2023 | 36596305 | PubTator, text mining | PubMed |
| Moving towards biologically informed treatment strategies for T-cell lymphomas. | Int J Hematol | 2023 | 36574170 | PubTator, text mining | PubMed |
| ARHGAP17 regulates the spatiotemporal activity of Cdc42 at invadopodia. | J Cell Biol | 2023 | 36571786 | PubTator, text mining | PubMed |
| The fusion oncogene VAV1-MYO1F triggers aberrant T-cell receptor signaling in vivo and drives peripheral T-cell lymphoma in mice. | Eur J Immunol | 2023 | 36541400 | PubTator, text mining | PubMed |
| Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency. | J Exp Med | 2023 | 36515678 | PubTator, text mining | PubMed |
| Identification of a novel mechanism for LFA-1 organization during NK cytolytic response. | J Cell Physiol | 2023 | 36477412 | PubTator, text mining | PubMed |
| Characterization of mutant versions of the R-RAS2/TC21 GTPase found in tumors. | Oncogene | 2023 | 36476833 | PubTator, text mining | PubMed |
| Cellular and metabolic characteristics of pre-leukemic hematopoietic progenitors with GATA2 haploinsufficiency. | Haematologica | 2023 | 36475518 | PubTator, text mining | PubMed |
| Syk Activation in Circulating and Tissue Innate Immune Cells in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. | Arthritis Rheumatol | 2023 | 36428281 | PubTator, text mining | PubMed |
| Dynamin-2 deficiency causes age- and sex-dependent neutropenia and myelodysplasia in mice. | Blood Adv | 2023 | 36417761 | PubTator, text mining | PubMed |
| A novel selective spleen tyrosine kinase inhibitor SKI-O-703 (cevidoplenib) ameliorates lupus nephritis and serum-induced arthritis in murine models. | Clin Exp Immunol | 2023 | 36346114 | PubTator, text mining | PubMed |
| Human natural killer cells: Form, function, and development. | J Allergy Clin Immunol | 2023 | 36195172 | PubTator, text mining | PubMed |
| RNA-regulatory exosome complex suppresses an apoptotic program to confer erythroid progenitor cell survival in vivo. | Blood Adv | 2023 | 36161469 | PubTator, text mining | PubMed |
| "ASXL1"-erating inflammation and bone marrow fibrosis in myeloproliferative neoplasms. | Haematologica | 2023 | 36005565 | PubTator, text mining | PubMed |
| ASXL1 mutations accelerate bone marrow fibrosis via EGR1-TNFA axis-mediated neoplastic fibrocyte generation in myeloproliferative neoplasms. | Haematologica | 2023 | 36005555 | PubTator, text mining | PubMed |
| KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy. | J Adv Res | 2023 | 35933091 | PubTator, text mining | PubMed |
| Cardiac Tamponade as a Recurrence of Angioimmunoblastic T-Cell Lymphoma with the Detection of a p.Gly17Val RHOA Mutation in the Pericardial Effusion. | Intern Med | 2023 | 35732446 | PubTator, text mining | PubMed |
| High intratumoral plasma cells content in primary prostate cancer defines a subset of tumors with potential susceptibility to immune-based treatments. | Prostate Cancer Prostatic Dis | 2023 | 35568781 | PubTator, text mining | PubMed |
| Epithelial RAC1-dependent cytoskeleton dynamics controls cell mechanics, cell shedding and barrier integrity in intestinal inflammation. | Gut | 2023 | 35241625 | PubTator, text mining | PubMed |
| Imatinib has minimal effects on inflammatory and osteopenic phenotypes in a murine cherubism model. | Oral Dis | 2023 | 34743383 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7409/papers?page=16